Novelix Pharmaceuticals Ltd — Updates, 15-07-2025: Company Update

Novelix Pharmaceuticals confirms compliance with share dematerialization rules for the quarter ending June 30, 2025. The company's Registrar & Share Transfer Agent verified and cancelled physical shares received for dematerialization. Subsequently, investor records with depositories (NSDL/CDSL) were promptly updated within the specified 15-day period. This ensures seamless and accurate conversion of physical shares into electronic format, crucial for maintaining operational efficiency and investor confidence in electronic shareholding.